Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Increased to $1,184 00 by Analysts at Royal Bank of Canada themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Oak Associates Ltd. OH grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.4% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 9,826 shares of the biopharmaceutical company’s stock after purchasing an additional 35 shares during […]
Natixis Advisors L P Sells 123 Shares of Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Jaffetilchin Investment Partners LLC Reduces Stake in Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Meiji Yasuda Life Insurance Co boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 33.8% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,348 shares of the biopharmaceutical company’s stock after purchasing an additional 593 shares during the […]